Correspondence 0001104659-24-092790 from PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: Aug. 26, 2024 · CIK: 0001985062 · Accession: 0001104659-24-092790
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281644
Letter
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario MK5 2K1
August 26, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed August 19, 2024
File No. 333-281644
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on Wednesday, August 28, 2024, or as soon as thereafter practicable.
Very truly yours,
PSYENCE BIOMEDICAL LTD.
Show Raw Text
CORRESP
1
filename1.htm
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario MK5 2K1
August 26, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed August 19, 2024
File No. 333-281644
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced
Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on Wednesday, August 28, 2024, or as soon as thereafter
practicable.
Very truly yours,
PSYENCE BIOMEDICAL LTD.
By:
/s/ Neil Maresky
Name:
Neil Maresky
Title:
Chief Executive Officer